Mouwasat Medical Services Inkomsten in het verleden
Verleden criteriumcontroles 2/6
Mouwasat Medical Services is de winst gegroeid met een gemiddeld jaarlijks percentage van 9.1%, terwijl de Healthcare industrie de winst jaarlijks groeide met 20.3%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 9.2% per jaar. Het rendement op eigen vermogen van Mouwasat Medical Services is 19.3%, en het heeft een nettomarge van 22.7%.
Belangrijke informatie
9.1%
Groei van de winst
9.1%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 12.3% |
| Inkomstengroei | 9.2% |
| Rendement op eigen vermogen | 19.3% |
| Nettomarge | 22.7% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Do Mouwasat Medical Services' (TADAWUL:4002) Earnings Warrant Your Attention?
Sep 30
The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing
Sep 12Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear
Aug 06Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?
Jul 01Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear
Apr 23Here's Why We Think Mouwasat Medical Services (TADAWUL:4002) Might Deserve Your Attention Today
Mar 18Slowing Rates Of Return At Mouwasat Medical Services (TADAWUL:4002) Leave Little Room For Excitement
Jan 23Here's Why Mouwasat Medical Services (TADAWUL:4002) Has Caught The Eye Of Investors
Dec 17Mouwasat Medical Services (TADAWUL:4002) Has Some Way To Go To Become A Multi-Bagger
Oct 05Should You Be Adding Mouwasat Medical Services (TADAWUL:4002) To Your Watchlist Today?
Sep 17The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing
Jul 03Is Now The Time To Put Mouwasat Medical Services (TADAWUL:4002) On Your Watchlist?
Jun 12Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down
Feb 24Mouwasat Medical Services Company's (TADAWUL:4002) Intrinsic Value Is Potentially 25% Below Its Share Price
Jan 18Return Trends At Mouwasat Medical Services (TADAWUL:4002) Aren't Appealing
Nov 24Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down
Aug 24A Look At The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Jul 01Time To Worry? Analysts Just Downgraded Their Mouwasat Medical Services Company (TADAWUL:4002) Outlook
May 23Mouwasat Medical Services (TADAWUL:4002) Will Pay A Larger Dividend Than Last Year At ر.س2.75
Apr 29Mouwasat Medical Services (TADAWUL:4002) Is Increasing Its Dividend To ر.س2.75
Apr 15Investors Will Want Mouwasat Medical Services' (TADAWUL:4002) Growth In ROCE To Persist
Mar 17Calculating The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Mar 02If You Like EPS Growth Then Check Out Mouwasat Medical Services (TADAWUL:4002) Before It's Too Late
Feb 15The Return Trends At Mouwasat Medical Services (TADAWUL:4002) Look Promising
Dec 06Do Mouwasat Medical Services's (TADAWUL:4002) Earnings Warrant Your Attention?
Nov 16Mouwasat Medical Services (TADAWUL:4002) Is Achieving High Returns On Its Capital
Aug 29Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?
Aug 12Is Mouwasat Medical Services Company (TADAWUL:4002) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 29Mouwasat Medical Services' (TADAWUL:4002) Returns On Capital Are Heading Higher
May 26Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?
May 11Is It Worth Buying Mouwasat Medical Services Company (TADAWUL:4002) For Its 1.4% Dividend Yield?
Apr 13Estimating The Intrinsic Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Mar 16Is Mouwasat Medical Services Company's (TADAWUL:4002) Latest Stock Performance Being Led By Its Strong Fundamentals?
Mar 02Is Mouwasat Medical Services (TADAWUL:4002) A Future Multi-bagger?
Feb 13Here's Why I Think Mouwasat Medical Services (TADAWUL:4002) Is An Interesting Stock
Feb 01
What Kind Of Shareholders Hold The Majority In Mouwasat Medical Services Company's (TADAWUL:4002) Shares?
Jan 17What Makes Mouwasat Medical Services Company (TADAWUL:4002) A Great Dividend Stock?
Jan 04Mouwasat Medical Services (TADAWUL:4002) Has Gifted Shareholders With A Fantastic 137% Total Return On Their Investment
Dec 21Estimating The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Dec 08Mouwasat Medical Services Company's (TADAWUL:4002) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
Nov 24Opbrengsten en kosten
Opbrengsten en kosten
Hoe Mouwasat Medical Services geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 2,897 | 658 | 613 | 0 |
| 30 Jun 24 | 2,827 | 665 | 576 | 0 |
| 31 Mar 24 | 2,764 | 663 | 564 | 0 |
| 31 Dec 23 | 2,706 | 658 | 547 | 0 |
| 30 Sep 23 | 2,593 | 659 | 472 | 0 |
| 30 Jun 23 | 2,501 | 625 | 464 | 0 |
| 31 Mar 23 | 2,431 | 616 | 446 | 0 |
| 31 Dec 22 | 2,334 | 599 | 419 | 0 |
| 30 Sep 22 | 2,226 | 561 | 396 | 0 |
| 30 Jun 22 | 2,208 | 581 | 383 | 0 |
| 31 Mar 22 | 2,177 | 581 | 372 | 0 |
| 31 Dec 21 | 2,144 | 578 | 360 | 0 |
| 30 Sep 21 | 2,125 | 574 | 369 | 0 |
| 30 Jun 21 | 2,143 | 593 | 373 | 0 |
| 31 Mar 21 | 2,085 | 567 | 369 | 0 |
| 31 Dec 20 | 2,045 | 528 | 371 | 0 |
| 30 Sep 20 | 2,016 | 515 | 364 | 0 |
| 30 Jun 20 | 1,911 | 447 | 355 | 0 |
| 31 Mar 20 | 1,889 | 422 | 357 | 0 |
| 31 Dec 19 | 1,857 | 421 | 349 | 0 |
| 30 Sep 19 | 1,808 | 376 | 367 | 0 |
| 30 Jun 19 | 1,769 | 364 | 370 | 0 |
| 31 Mar 19 | 1,717 | 361 | 367 | 0 |
| 31 Dec 18 | 1,677 | 360 | 361 | 0 |
| 30 Sep 18 | 1,652 | 373 | 359 | 0 |
| 30 Jun 18 | 1,608 | 369 | 345 | 0 |
| 31 Mar 18 | 1,567 | 358 | 337 | 0 |
| 31 Dec 17 | 1,507 | 337 | 334 | 0 |
| 30 Sep 17 | 1,435 | 314 | 318 | 0 |
| 30 Jun 17 | 1,356 | 286 | 307 | 0 |
| 31 Mar 17 | 1,303 | 274 | 296 | 0 |
| 31 Dec 16 | 1,243 | 257 | 284 | 0 |
| 30 Sep 16 | 1,144 | 235 | 254 | 0 |
| 30 Jun 16 | 1,095 | 229 | 236 | 0 |
| 31 Mar 16 | 1,050 | 221 | 220 | 0 |
| 31 Dec 15 | 1,000 | 209 | 209 | 0 |
| 30 Sep 15 | 926 | 206 | 157 | 0 |
| 30 Jun 15 | 925 | 235 | 167 | 0 |
| 31 Mar 15 | 914 | 238 | 175 | 0 |
| 31 Dec 14 | 904 | 240 | 179 | 0 |
| 30 Sep 14 | 961 | 240 | 245 | 0 |
| 30 Jun 14 | 942 | 212 | 242 | 0 |
| 31 Mar 14 | 927 | 207 | 238 | 0 |
| 31 Dec 13 | 902 | 201 | 229 | 0 |
Kwaliteitswinsten: 4002 heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (22.7%) 4002 } zijn lager dan vorig jaar (25.4%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van 4002 is de afgelopen 5 jaar met 9.1% per jaar gegroeid.
Versnelling van de groei: De winstgroei 4002 is het afgelopen jaar negatief geweest en kan daarom niet worden vergeleken met het 5-jarig gemiddelde.
Winst versus industrie: 4002 had het afgelopen jaar een negatieve winstgroei ( -0.1% ), waardoor het moeilijk is om te vergelijken met het branchegemiddelde Healthcare ( 15.7% ).
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 19.3% ) van 4002 wordt als laag beschouwd.